Price (delayed)
$2.38
Market cap
$95.94M
P/E Ratio
21.64
Dividend/share
N/A
EPS
$0.11
Enterprise value
$54.27M
Oramed Pharmaceuticals is a platform technology pioneer in the field of oral delivery solutions for drugs currently delivered via injection. Established in 2006, with offices in the United States and
There are no recent dividends present for ORMP.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.